⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL28522851 | 0.89 | — | — | |
| SCHEMBL4672200 | 0.89 | — | — | |
| Fluoride SCHEMBL27602882 | 0.80 | — | — | |
| SCHEMBL657533 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL2244525 | 0.80 | — | — | |
| Bromide SCHEMBL1473376 | 0.80 | — | — | |
| SCHEMBL5640 | 0.78 | — | — | |
| SCHEMBL10417889 | 0.78 | — | — | |
| SCHEMBL15869348 | 0.78 | — | — | |
| SCHEMBL19876982 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3621940-A1 | COMPOSITIONS AND METHODS FOR PREPARING , -UNSATURATED ACIDS | California Institute of Technology (US) | 2020-03-18 | — | — | EP | claimed |
| WO-2018209243-A1 | COMPOSITIONS AND METHODS FOR PREPARING β,γ-UNSATURATED ACIDS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-11-15 | — | — | WO | claimed |
| EP-3883926-B1 | BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDE DERIVATIVES AND PROTEIN CONJUGATES THEREOF FOR USE AS LXR AGONISTS | REGENERON PHARMA (US) | 2024-07-10 | — | — | EP | disclosed |
| EP-4376895-A2 | PROTEIN-ANTIVIRAL COMPOUND CONJUGATES | Regeneron Pharmaceuticals, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-118027137-A | Tubulysin and protein-tubulysin conjugates | 里珍纳龙药品有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117813119-A | Protein-antiviral compound conjugates | 里珍纳龙药品有限公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20240100179-A1 | PROTEIN-ANTIVIRAL COMPOUND CONJUGATES | REGENERON PHARMACEUTICALS, INC. | 2024-03-28 | — | — | US | disclosed |
| US-20230414775-A1 | TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES | REGENERON PHARMACEUTICALS, INC. | 2023-12-28 | — | — | US | disclosed |
| WO-2023244815-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | MONTE ROSA THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023244818-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | MONTE ROSA THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| US-11752214-B2 | Protein-antiviral compound conjugates | REGENERON PHARMACEUTICALS, INC. (US) | 2023-09-12 | — | — | US | disclosed |
| EP-2014700-A1 | POLYMERIZABLE COMPOSITION, RESIN USING THE SAME AND OPTICAL COMPONENT | Mitsui Chemicals, Inc. (JP) | 2009-01-14 | — | — | EP | disclosed |
| CN-1286883-C | Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS INC (JP) | 2006-11-29 | — | — | CN | disclosed |
| US-7132501-B2 | Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS, INC. (JP) | 2006-11-07 | — | — | US | disclosed |
| US-20050215757-A1 | Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS, INC. (JP) | 2005-09-29 | — | — | US | disclosed |
| CN-1596276-A | Polymerizable composition comprising novel sulfur-containing cyclic compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS INC (JP) | 2005-03-16 | — | — | CN | disclosed |
| EP-1482002-A1 | POLYMERIZABLE COMPOSITION CONTAINING NOVEL CYCLIC SULFUR COMPOUND AND RESIN OBTAINED BY CURING THE POLYMERIZABLE COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2004-12-01 | — | — | EP | disclosed |
| US-20040082642-A1 | Novel estrogen receptor ligands and method III | MERCK & CO., INC. | 2004-04-29 | — | — | US | disclosed |
| EP-1339662-A1 | NOVEL ESTROGEN RECEPTOR LIGANDS AND METHODS III | KARO BIO AB (SE) | 2003-09-03 | — | — | EP | disclosed |
| WO-2002046134-A1 | NOVEL ESTROGEN RECEPTOR LIGANDS AND METHODS III | KARO BIO AB (SE) | 2002-06-13 | — | — | WO | disclosed |